PL1968634T3 - Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b - Google Patents

Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b

Info

Publication number
PL1968634T3
PL1968634T3 PL06847150T PL06847150T PL1968634T3 PL 1968634 T3 PL1968634 T3 PL 1968634T3 PL 06847150 T PL06847150 T PL 06847150T PL 06847150 T PL06847150 T PL 06847150T PL 1968634 T3 PL1968634 T3 PL 1968634T3
Authority
PL
Poland
Prior art keywords
immunoglobulin
igg
antibodies
preparing
concentrate depleted
Prior art date
Application number
PL06847150T
Other languages
English (en)
Inventor
Abdessatar Chtourou
Frédéric Dhainaut
Philippe Paolantonacci
Original Assignee
Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36956126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1968634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa filed Critical Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa
Publication of PL1968634T3 publication Critical patent/PL1968634T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
PL06847150T 2005-12-26 2006-12-26 Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b PL1968634T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0513311A FR2895263B1 (fr) 2005-12-26 2005-12-26 Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
PCT/FR2006/002889 WO2007077365A2 (fr) 2005-12-26 2006-12-26 CONCENTRE D’IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B, ET EN IgG POLYREACTIVES
EP06847150.7A EP1968634B1 (fr) 2005-12-26 2006-12-26 PROCÉDÉ DE PRÉPARATION DE CONCENTRE D' IMMUNOGLOBULINES G (IgG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B

Publications (1)

Publication Number Publication Date
PL1968634T3 true PL1968634T3 (pl) 2015-03-31

Family

ID=36956126

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06847150T PL1968634T3 (pl) 2005-12-26 2006-12-26 Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b
PL11162751T PL2345425T3 (pl) 2005-12-26 2006-12-26 Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11162751T PL2345425T3 (pl) 2005-12-26 2006-12-26 Koncentrat immunoglobulin G (IgG) zubożony w przeciwciała anty-A i anty-B oraz w polireaktywne IgG

Country Status (15)

Country Link
US (1) US8153382B2 (pl)
EP (3) EP2345425B1 (pl)
JP (3) JP5726403B2 (pl)
KR (1) KR101250095B1 (pl)
CN (3) CN102921004A (pl)
AU (1) AU2006334278B2 (pl)
BR (1) BRPI0620600B1 (pl)
CA (1) CA2634997C (pl)
DK (2) DK1968634T3 (pl)
ES (2) ES2517540T3 (pl)
FR (1) FR2895263B1 (pl)
IL (2) IL192289A (pl)
PL (2) PL1968634T3 (pl)
TR (1) TR201814658T4 (pl)
WO (1) WO2007077365A2 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
FR2939667B1 (fr) * 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
FR2940617B1 (fr) 2008-12-30 2012-04-20 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobulines g
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
FR2949195B1 (fr) 2009-08-24 2011-10-14 Lfb Biomedicaments Poche de stockage de solution therapeutique
FR2952826B1 (fr) 2009-11-20 2012-04-06 Lab Francais Du Fractionnement Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique
EP2566879A4 (en) * 2010-05-05 2013-09-11 Arryx Inc METHOD FOR FUNCTIONALIZATION OF HUMAN RED GLOBES USING ANTIBODIES
FR2959821B1 (fr) 2010-05-05 2012-07-06 Lab Francais Du Fractionnement Procede de mesure de l'activation du complement par des igg
FR2961107B1 (fr) * 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
FR2962650B1 (fr) 2010-07-19 2013-04-05 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines concentrees
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2977893B1 (fr) * 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
US20140323315A1 (en) 2013-04-29 2014-10-30 Adimab, Llc Polyspecificity reagents, methods for their preparation and use
US10611826B2 (en) * 2013-07-05 2020-04-07 Laboratoire Français Du Fractionnement Et Des Biotechnologies Affinity chromatography matrix
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
FR3026950A1 (fr) * 2014-10-09 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de plasma universel
FR3035799B1 (fr) * 2015-05-06 2017-05-05 Elicityl Support pour la purification de liquides biologiques
FR3035794B1 (fr) * 2015-05-06 2017-05-05 Elicityl Procede pour la purification du sang total ou d'un produit issu du sang
FR3035971A1 (fr) 2015-05-07 2016-11-11 Lab Francais Du Fractionnement Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b
US10697983B2 (en) 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of media suitable for removing anti-A or anti-B antibodies
US10697982B2 (en) * 2015-09-08 2020-06-30 Merck Patent Gmbh Methods of evaluating quality of a chromatography media which binds anti-A or anti-B antibodies
US20170066839A1 (en) * 2015-09-08 2017-03-09 Merck Patent Gmbh Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies
WO2017078947A1 (en) * 2015-10-21 2017-05-11 Cambryn Biologics, Llc Processes for purifying proteins from plasma
FR3076294B1 (fr) 2017-12-29 2022-01-28 Lab Francais Du Fractionnement Procede de purification d'anticorps a partir de lait brut
CN108101981B (zh) 2018-01-15 2019-06-04 四川远大蜀阳药业有限责任公司 一种静注免疫球蛋白的生产工艺
CN109239335A (zh) * 2018-09-11 2019-01-18 广州万孚生物技术股份有限公司 联检试纸条及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR513311A (fr) 1916-05-04 1921-02-12 Raphael Von Ostrejko Procédé et installation pour la préparation de charbon décolorant
US4664913A (en) 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
DK166763C (da) 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
JPS622162A (ja) * 1985-06-28 1987-01-08 Mutsuo Kitahama 抗ｂモノクロ−ナル抗体およびその製造法
JPH0662436B2 (ja) 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
AT391810B (de) 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
ATE122054T1 (de) 1990-03-22 1995-05-15 Biotest Pharma Gmbh Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
JPH07509783A (ja) * 1992-10-30 1995-10-26 ティー　セル　ダイアグノスティックス，インコーポレーテッド 試料中の全分子の測定及びそれに基づく方法
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
CA2136698A1 (en) 1994-11-25 1996-05-26 M. Abdul Mazid Resin compositions and methods for their use
US5776711A (en) 1996-11-12 1998-07-07 The Regents Of The University Of California Simultaneous human ABO and RH(D) blood typing or antibody screening by flow cytometry
PT1084147E (pt) 1998-06-09 2005-01-31 Statens Seruminstitut Processo para producao de imunoglobulinas para administracao intravenosa e outros produtos de imunoglobulina
ES2561418T3 (es) * 1999-06-03 2016-02-26 Advanced Extravascular Systems Eliminación en una sola fase de moléculas no deseadas en la sangre circulante
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
ATE298889T1 (de) 1999-10-08 2005-07-15 Vi Technologies Inc Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
ES2304378T3 (es) 2000-02-08 2008-10-16 Glycorex Transplantation Ab Soportes oligosacaridos para por ejemplo retirar anticuerpos de la sangre.
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
JP4493882B2 (ja) * 2001-06-19 2010-06-30 株式会社カネカ 抗原およびこの抗原を識別するモノクローナル抗体
US20040101909A1 (en) 2002-08-20 2004-05-27 Hema-Quebec, 2535 Boul. Laurier, Ste-Foy, Quebec, Canada G1V 4M3 Purification of polyreactive autoantibodies and uses thereof
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Also Published As

Publication number Publication date
CA2634997C (en) 2017-07-18
AU2006334278A1 (en) 2007-07-12
EP1968634A2 (fr) 2008-09-17
WO2007077365A3 (fr) 2007-08-30
CN102921004A (zh) 2013-02-13
ES2690664T3 (es) 2018-11-21
CN103394084B (zh) 2016-04-27
BRPI0620600B1 (pt) 2022-01-04
US8153382B2 (en) 2012-04-10
CN103394084A (zh) 2013-11-20
FR2895263B1 (fr) 2008-05-30
CN101346153A (zh) 2009-01-14
TR201814658T4 (tr) 2018-11-21
JP2009521520A (ja) 2009-06-04
IL192289A0 (en) 2008-12-29
IL192289A (en) 2014-11-30
ES2517540T3 (es) 2014-11-03
KR101250095B1 (ko) 2013-04-03
CA2634997A1 (en) 2007-07-12
US20090074749A1 (en) 2009-03-19
EP2792366A1 (fr) 2014-10-22
PL2345425T3 (pl) 2019-01-31
CN101346153B (zh) 2013-08-14
DK2345425T3 (en) 2018-10-29
EP2345425B1 (fr) 2018-07-11
AU2006334278B2 (en) 2012-11-01
IL231806A0 (en) 2014-05-28
JP2015091866A (ja) 2015-05-14
BRPI0620600A2 (pt) 2011-11-16
JP2013151507A (ja) 2013-08-08
DK1968634T3 (da) 2014-10-13
KR20080098486A (ko) 2008-11-10
WO2007077365A2 (fr) 2007-07-12
EP1968634B1 (fr) 2014-07-16
JP5944543B2 (ja) 2016-07-05
FR2895263A1 (fr) 2007-06-29
JP5726403B2 (ja) 2015-06-03
EP2345425A2 (fr) 2011-07-20
EP2345425A3 (fr) 2011-12-28
IL231806A (en) 2017-04-30

Similar Documents

Publication Publication Date Title
PL1968634T3 (pl) Sposób wytwarzania koncentratu immunoglobulin g (igg) zubożonego pod względem przeciwciał anty-a i anty-b
IL187683A (en) Methods for purifying antibodies against a beta
IL231169A0 (en) Human monoclonal antibodies to fucosil - 1gm and methods of using antibodies against fucosil - 1gm
EP1874820A4 (en) HIGH AFFINE, COMPLETELY HUMAN MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-8 AND EPITOPES FOR SUCH ANTIBODIES
TWI370137B (en) Human monoclonal antibodies to activin receptor-like kinase-1
HK1151305A1 (zh) 用於治療癌症的針對密蛋白- 的單克隆抗體
IL202232A0 (en) Novel rabbit antibody humanization methods and humanized rabbit antibodies
EP1910513A4 (en) METHOD OF ISOLATING CELLS AND PRODUCING MONOCLONAL ANTIBODIES
ZA201000093B (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
IL179672A (en) Monoclonal antibodies against 3 cd human
IL213618A0 (en) Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system
EP1930025A4 (en) ANTIGEN-AND-ARZNEI VEHICLE FOR ENABLING THE CONVERSION FROM THE SELECTIVE PRODUCTION OF AN IGA ANTIBODY TO THE PRODUCTION OF IGA AND IGG ANTIBODIES AND TRANSNASAL / MUCOSAL VACCINE WITH THIS VEHICLE
IL180854A (en) Methods for producing antibodies against vegf
IL197459A0 (en) Humanized proteins, including antibodies and methods for producing the same
IL180152A0 (en) Chimeric and humanised monoclonal antibodies against inteleukin-13
EP1940864A4 (en) PROCESS FOR GENERATING MONOCLONAL ANTIBODIES WITH A VIVO REGION
HK1098825A1 (en) Human monoclonal antibodies against cd20
HK1109585A1 (en) Humanized amyloid beta antibodies for use in improving cognition
IL181316A0 (en) Method of using death receptor ligands and cd20 antibodies
EP2233503A4 (en) MONOCLONAL ANTI-OFLOXACIN ANTIBODIES AND IMMUNASSAY METHOD ON OFLOXACIN USING THEREOF
IL210870A0 (en) Method of determination of receptor binding saturation effected by monoclonal antibodies
EP2114996A4 (en) ALLERGEN BINDING IGE MONOCLONAL ANTIBODIES AND METHOD FOR PREPARING HYPOALLERGENES
AU2013206196B9 (en) Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs
EP2150346A4 (en) DEVICE AND METHOD FOR SEPARATING PROTEINS AND OTHER BIOMOLECULES
AU2009334626B2 (en) Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system